SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Thomas M. who wrote (1083)12/1/1999 1:53:00 PM
From: BiomavenRead Replies (2) of 4974
 
Thomas,

The placebo response is a huge problem for many trials. There are areas like urinary incontinence where they are very hard pressed to come up with statistical significance despite large trials - the people on placebo just keep improving throughout the trial.

Often the placebo works even better in a trial than it "should" - look at CLGY for a recent example.

I wonder whether companies have fantasized about an "anti-placebo" message - "Remember, you may just be getting a sugar pill. On no account get better just because you think you're getting something good ..." <g>

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News